Insulin resistance is the cornerstone of NAFLD development, and the decline in insulin sensitivity in peripheral tissues, particularly accompanied by elevated compensatory hyperinsulinemia, promotes the uptake of free fatty acids by the liver and lipogenesis, leading to steatosis. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.